Drug Therapy
US Congress 114th Congress
Ensuring Equal Access to Treatments Act of 2015 [S.1466]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Social Security ]
Ensuring Equal Access to Treatments Act of 2015 Amends title XVIII (Medicare) of the Social Security Act, with respect to the prospective payment system for hospital outpatient department (OPD) services, to direct the Secretary of Health and Human Services to create certain additional groups of covered OPD services that classify separately, from those that do not utilize such a drug, procedures that utilize a drug (other than contrast agents, diagnostic radiopharmaceutical, or anesthesia drugs) that both has a cost above the drug packaging threshold
(continued...)
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Finance. on 05/22/2015
Spread the world
Gettr US Congress 114th Congress
Recovery Enhancement for Addiction Treatment Act TREAT Act [S.1455]
[Healthcare ]
[Public Health ]
[Mental Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Law Enforcement ]
[Crime ]
Recovery Enhancement for Addiction Treatment Act TREAT Act Amends the Controlled Substances Act to increase the number of patients that a qualifying practitioner dispensing narcotic drugs for maintenance or detoxification treatment is initially allowed to treat from 30 to 100 patients per year. Allows a qualifying physician, after one year, to request approval to treat an unlimited number of patients under specified conditions, including that he or she: (1) agrees to fully participate in the Prescription Drug Monitoring Program of the state in which
(continued...)
Sponsored by: Sen. Robert Casey
Committee On Health, Education, Labor, And Pensions. Reported By Senator Alexander With An Amendment In The Nature Of A Substitute. Without Written Report. on 04/27/2016
Spread the world
US Congress 114th Congress
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015 [S.1421]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015 Amends the Federal Food, Drug, and Cosmetic Act to require the Department of Health and Human Services (HHS) to extend by six months the exclusivity period for a drug or biological product approved by the Food and Drug Administration (FDA) when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an “orphan disease”). Allows HHS to revoke an extension if the application submitted to the FDA
(continued...)
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/21/2015
Spread the world
US Congress 114th Congress
Treatment and Recovery Investment Act [S.1410]
[Healthcare ]
[Public Health ]
[Mental Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Grants ]
[Funding ]
[Human Services ]
[Children and Youth ]
Treatment and Recovery Investment Act This bill amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to state agencies responsible for administering funds received under the substance abuse prevention and treatment block grant program, to local governments that have a high rate of, or have had a rapid increase in, the use of, or death related to the use of, heroin or other opioids (including prescription opioids), and to Indian tribes or tribal organizations in order to permit such entities to
(continued...)
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/21/2015
Spread the world
US Congress 114th Congress
Safer Prescribing of Controlled Substances Act [S.1392]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Mental Health ]
[Law Enforcement ]
Safer Prescribing of Controlled Substances Act Amends the Controlled Substances Act to direct the Attorney General, as a condition of granting or renewing the registration of a covered practitioner to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, to require such covered practitioner to complete training that the Department of Health and Human Services (HHS) determines meets the requirements of this Act. Defines a "covered practitioner" as a practitioner that is not a hospital, pharmacy, or veterinarian.
(continued...)
Sponsored by: Sen. Dianne Feinstein
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/20/2015
Spread the world
US Congress 114th Congress
CCM-CARE Act Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2015 [S.1391]
[Healthcare ]
[Science ]
[Public Health ]
[Grants ]
[Pharmaceuticals ]
CCM-CARE Act Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2015 This bill amends the Public Health Service Act to require the National Institutes of Health (NIH) to strengthen and coordinate its efforts concerning cerebral cavernous malformation (CCM). (CCM is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, or bleeding in the brain.) The NIH may award grants and enter into cooperative agreements for CCM research.
(continued...)
Sponsored by: Sen. Tom Udall
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/20/2015
Spread the world
US Congress 114th Congress
Access to Quality Diabetes Education Act of 2015 [S.1345]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Education ]
[Science ]
[Senior Citizens ]
[Social Security ]
Access to Quality Diabetes Education Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to recognize state-licensed or -registered certified diabetes educators or state-licensed or -registered health care professionals who specialize in teaching individuals with diabetes to develop the necessary skills and knowledge to manage the individual's diabetic condition and are certified as a diabetes educator by a recognized certifying body. Directs the Government Accountability Office to study the barriers that exist for Medicare beneficiaries
(continued...)
Sponsored by: Sen. Amy Klobuchar
Read Twice And Referred To The Committee On Finance. on 05/14/2015
Spread the world
US Congress 114th Congress
Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 [S.1134]
[Healthcare ]
[Crime ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Veterans ]
Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration, to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication. The Harold Rogers Prescription Drug Monitoring Program is extended through FY2020. The Government Accountability
(continued...)
Sponsored by: Sen. Joe Donnelly
Read Twice And Referred To The Committee On The Judiciary. on 04/29/2015
Spread the world
US Congress 114th Congress
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015 [HB-971]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015 Amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to extend by six months the exclusivity period for an approved drug or biological product when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an “orphan disease”). Allows the FDA to revoke an extension if the application for the new indication contained an untrue material statement. Requires
(continued...)
Sponsored by: Rep. Steve Scalise
Referred To The Subcommittee On Health. on 02/20/2015
Spread the world
US Congress 114th Congress
Comprehensive Addiction and Recovery Act of 2015 [HB-953]
[Healthcare ]
[Crime ]
[Public Health ]
[Law Enforcement ]
Comprehensive Addiction and Recovery Act of 2015 Directs the Department of Health and Human Services (HHS) to convene a Pain Management Best Practices Inter-Agency Task Force to develop: (1) best practices for pain management and prescribing pain medication, and (2) a strategy for disseminating such best practices. Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General to make grants to: states (with priority to states that provide civil liability protection for first responders, health professionals, and
(continued...)
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Higher Education And Workforce Training. on 04/29/2015
Spread the world
US Congress 114th Congress
Andrea Sloan CURE Act Andrea Sloan Compassionate Use Reform and Enhancement Act [HB-909]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Andrea Sloan CURE Act Andrea Sloan Compassionate Use Reform and Enhancement Act Amends the Federal Food, Drug, and Cosmetic Act to require the sponsor of an “investigational drug” (which is a drug that is designated as a breakthrough therapy, fast track product, infectious disease product, or drug for a rare disease or condition) to submit to the Food and Drug Administration (FDA) and make available to the public the sponsor's policy on requests for expanded access to the unapproved drug, including the minimum criteria for considering or approving
(continued...)
Sponsored by: Rep. H. Morgan Griffith
Referred To The Subcommittee On Health. on 02/13/2015
Spread the world
US Congress 114th Congress
Compassionate Freedom of Choice Act of 2015 [HB-790]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Compassionate Freedom of Choice Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act prevents or restricts, and the Food and Drug Administration (FDA) must not prevent or restrict, the manufacture, importation, distribution, or sale of investigational drugs or devices for terminally ill patients. The FDA is prohibited from requiring the disclosure, collection, or reporting of certain information concerning such drugs or devices, except that the sponsor of a clinical
(continued...)
Sponsored by: Rep. H. Morgan Griffith
Referred To The Subcommittee On Health. on 02/06/2015
Spread the world
US Congress 114th Congress
Medicare Home Infusion Site of Care Act of 2015 [HB-605]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Social Security ]
[Senior Citizens ]
Medicare Home Infusion Site of Care Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to authorize Medicare coverage of home infusion therapy and home infusion drugs. Directs the Secretary of Health and Human Services to implement the Medicare home infusion therapy benefit in a manner that ensures that: (1) Medicare beneficiaries have timely and appropriate access to infusion therapy in their homes, and (2) there is rapid and seamless coordination between drug coverage under Medicare part D (Voluntary Prescription Drug Benefit
(continued...)
Sponsored by: Rep. David Valadao
Referred To The Subcommittee On Health. on 02/27/2015
Spread the world
US Congress 114th Congress
21st Century Cures Act [HB-6]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Public Health ]
[Science ]
[Technology and Innovation ]
[Funding ]
[Grants ]
21st Century Cures Act (Sec. 2) The NIH and Cures Innovation Fund is established and funds are appropriated: (1) for biomedical research, including high-risk, high-reward research and research conducted by early stage investigators; (2) to develop and implement a strategic plan for biomedical research; and (3) to carry out specified provisions of this Act. TITLE I--DISCOVERY Subtitle A--National Institutes of Health Funding (Sec. 1001) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018.
(continued...)
Sponsored by: Rep. Steve Scalise
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/13/2015
Spread the world
US Congress 114th Congress
RACE for Children Act Research to Accelerate Cures and Equity for Children Act [HB-5858]
[Healthcare ]
[Public Health ]
[Children and Youth ]
[Science ]
RACE for Children Act Research to Accelerate Cures and Equity for Children Act
Sponsored by: Rep. Daniel Lipinski
Introduced In House on 07/14/2016
Spread the world
US Congress 114th Congress
Medicaid Data and Benefit Improvement Act of 2016 [HB-5717]
[Healthcare ]
[Medicare and Medicaid ]
[Data Privacy ]
Medicaid Data and Benefit Improvement Act of 2016
Sponsored by: Rep. Leonard Lance
Introduced In House on 07/11/2016
Spread the world
US Congress 114th Congress
GAO Mandates Revision Act of 2016 [HB-5687]
[Finance ]
[Medicare and Medicaid ]
[Healthcare ]
[Consumer Protection ]
[Public Health ]
[Funding ]
[Grants ]
GAO Mandates Revision Act of 2016 (Sec. 2) This bill eliminates provisions that require the Government Accountability Office (GAO) to: review reported legislation that requires financial audits of nonfederal entities receiving federal awards; evaluate the extent to which premium levels for Medicare supplemental policies reflect reductions in coinsurance for hospital outpatient services made by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 under part B (Supplementary Medical Insurance Benefits for Aged and Disabled)
(continued...)
Sponsored by: Rep. Jody Hice
Became Public Law No: 114-301. on 12/16/2016
Spread the world
US Congress 114th Congress
Addiction Prevention and Responsible Opioid Practices Act [HB-5655]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Mental Health ]
Addiction Prevention and Responsible Opioid Practices Act
Sponsored by: Rep. Eleanor Norton
Referred To The Subcommittee On Crime, Terrorism, Homeland Security, And Investigations. on 07/20/2016
Spread the world
US Congress 114th Congress
Medical Marijuana Research Act of 2016 [HB-5549]
[Cannabis ]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Science ]
Medical Marijuana Research Act of 2016
Sponsored by: Rep. H. Morgan Griffith
Referred To The Subcommittee On Crime, Terrorism, Homeland Security, And Investigations. on 06/27/2016
Spread the world
US Congress 114th Congress
STOP OD Act of 2016 Stem the Tide of Overdose Prevalence from Opiate Drugs Act of 2016 [HB-5432]
[Healthcare ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Public Health ]
STOP OD Act of 2016 Stem the Tide of Overdose Prevalence from Opiate Drugs Act of 2016
Sponsored by: Rep. Tim Ryan
Referred To The Subcommittee On Military Personnel. on 06/16/2016